Dave A. Miller

2.6k total citations
48 papers, 1.9k citations indexed

About

Dave A. Miller is a scholar working on Pharmaceutical Science, Materials Chemistry and Food Science. According to data from OpenAlex, Dave A. Miller has authored 48 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pharmaceutical Science, 17 papers in Materials Chemistry and 10 papers in Food Science. Recurrent topics in Dave A. Miller's work include Drug Solubulity and Delivery Systems (37 papers), Advanced Drug Delivery Systems (18 papers) and Crystallization and Solubility Studies (17 papers). Dave A. Miller is often cited by papers focused on Drug Solubulity and Delivery Systems (37 papers), Advanced Drug Delivery Systems (18 papers) and Crystallization and Solubility Studies (17 papers). Dave A. Miller collaborates with scholars based in United States, Germany and Switzerland. Dave A. Miller's co-authors include Robert O. Williams, James W. McGinity, James C. DiNunzio, Wei Yang, Chris Brough, Justin R. Hughey, Justin M. Keen, Jason T. McConville, Keith P. Johnston and Dieter Lubda and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, International Journal of Pharmaceutics and Pharmaceutical Research.

In The Last Decade

Dave A. Miller

47 papers receiving 1.8k citations

Peers

Dave A. Miller

SPECT

Yohei Kawabata Japan

Harpreet Sandhu United States

Niall J. O’Reilly Ireland

Hassan Benameur Australia

Helen Cathcart Ireland

Claudia S. Leopold Germany

Chris Brough United States

Norbert Rasenack Germany

Hossein Zia United States

Zelalem Ayenew Worku Ireland

Yohei Kawabata Japan

Dave A. Miller

1.2k ×0.8

509 ×0.8

326 ×0.8

167 ×0.6

206 ×0.8

SPECT

Citations per year, relative to Dave A. Miller Dave A. Miller (= 1×) peers Yohei Kawabata

Countries citing papers authored by Dave A. Miller

Since Specialization

Citations

This map shows the geographic impact of Dave A. Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dave A. Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dave A. Miller more than expected).

Fields of papers citing papers by Dave A. Miller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dave A. Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dave A. Miller. The network helps show where Dave A. Miller may publish in the future.

Co-authorship network of co-authors of Dave A. Miller

This figure shows the co-authorship network connecting the top 25 collaborators of Dave A. Miller. A scholar is included among the top collaborators of Dave A. Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dave A. Miller. Dave A. Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jara, Miguel O., et al.. (2025). Comparative study of Hot-Melt Extrusion, spray drying, and KinetiSol® processing to formulate a poorly water-soluble and thermolabile drug. International Journal of Pharmaceutics. 676. 125582–125582. 2 indexed citations

Davis, Daniel A., et al.. (2021). Formulating a heat- and shear-labile drug in an amorphous solid dispersion: Balancing drug degradation and crystallinity. International Journal of Pharmaceutics X. 3. 100092–100092. 14 indexed citations

Miller, Dave A., et al.. (2021). The effect of drug loading on the properties of abiraterone–hydroxypropyl beta cyclodextrin solid dispersions processed by solvent free KinetiSol® technology. European Journal of Pharmaceutics and Biopharmaceutics. 165. 52–65. 18 indexed citations

Tan, Deck Khong, Daniel A. Davis, Dave A. Miller, Robert O. Williams, & Ali Nokhodchi. (2020). Innovations in Thermal Processing: Hot-Melt Extrusion and KinetiSol® Dispersing. AAPS PharmSciTech. 21(8). 312–312. 41 indexed citations

Davis, Daniel A., Dave A. Miller, Yongchao Su, & Robert O. Williams. (2020). Thermally Conductive Excipient Expands KinetiSol® Processing Capabilities. AAPS PharmSciTech. 21(8). 319–319. 16 indexed citations

Miller, Dave A., et al.. (2019). Harnessing the therapeutic potential of anticancer drugs through amorphous solid dispersions. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1873(1). 188319–188319. 83 indexed citations

Miller, Dave A., et al.. (2018). Improved Vemurafenib Dissolution and Pharmacokinetics as an Amorphous Solid Dispersion Produced by KinetiSol® Processing. AAPS PharmSciTech. 19(5). 1957–1970. 24 indexed citations

Brough, Chris, et al.. (2016). Use of Polyvinyl Alcohol as a Solubility Enhancing Polymer for Poorly Water-Soluble Drug Delivery (Part 2). AAPS PharmSciTech. 17(1). 180–190. 29 indexed citations

Brough, Chris, Dave A. Miller, Justin M. Keen, et al.. (2015). Use of Polyvinyl Alcohol as a Solubility-Enhancing Polymer for Poorly Water Soluble Drug Delivery (Part 1). AAPS PharmSciTech. 17(1). 167–179. 77 indexed citations

10.

LaFountaine, Justin S., Leena Kumari Prasad, Chris Brough, et al.. (2015). Thermal Processing of PVP- and HPMC-Based Amorphous Solid Dispersions. AAPS PharmSciTech. 17(1). 120–132. 56 indexed citations

11.

Brough, Chris, Dave A. Miller, K.P. O’Donnell, et al.. (2013). Preparation of amorphous solid dispersions by rotary evaporation and KinetiSol Dispersing: approaches to enhance solubility of a poorly water-soluble gum extract. Drug Development and Industrial Pharmacy. 41(3). 382–397. 30 indexed citations

12.

Hughey, Justin R., Justin M. Keen, Dave A. Miller, et al.. (2013). The use of inorganic salts to improve the dissolution characteristics of tablets containing Soluplus®-based solid dispersions. European Journal of Pharmaceutical Sciences. 48(4-5). 758–766. 80 indexed citations

13.

Hughey, Justin R., Justin M. Keen, Dave A. Miller, Chris Brough, & James W. McGinity. (2012). Preparation and characterization of fusion processed solid dispersions containing a viscous thermally labile polymeric carrier. International Journal of Pharmaceutics. 438(1-2). 11–19. 35 indexed citations

14.

DiNunzio, James C., Chris Brough, Dave A. Miller, Robert O. Williams, & James W. McGinity. (2010). Applications of KinetiSol® Dispersing for the production of plasticizer free amorphous solid dispersions. European Journal of Pharmaceutical Sciences. 40(3). 179–187. 51 indexed citations

15.

DiNunzio, James C., Chris Brough, Justin R. Hughey, et al.. (2009). Fusion production of solid dispersions containing a heat-sensitive active ingredient by hot melt extrusion and Kinetisol® dispersing. European Journal of Pharmaceutics and Biopharmaceutics. 74(2). 340–351. 108 indexed citations

16.

Miller, Dave A., James C. DiNunzio, Wei Yang, James W. McGinity, & Robert O. Williams. (2008). Enhanced In Vivo Absorption of Itraconazole via Stabilization of Supersaturation Following Acidic-to-Neutral pH Transition. Drug Development and Industrial Pharmacy. 34(8). 890–902. 124 indexed citations

17.

Miller, Dave A., James C. DiNunzio, Wei Yang, James W. McGinity, & Robert O. Williams. (2008). Targeted Intestinal Delivery of Supersaturated Itraconazole for Improved Oral Absorption. Pharmaceutical Research. 25(6). 1450–1459. 101 indexed citations

18.

Overhoff, Kirk A., Alejandro Moreno, Dave A. Miller, Keith P. Johnston, & Robert O. Williams. (2006). Solid dispersions of itraconazole and enteric polymers made by ultra-rapid freezing. International Journal of Pharmaceutics. 336(1). 122–132. 68 indexed citations

19.

Miller, Dave A., et al.. (1988). A model to evaluate whether a community can support a physician. Academic Medicine. 63(7). 515–21. 3 indexed citations

20.

Welton, Ann F., William C. Hope, Mike O’Donnell, et al.. (1984). Ro 22-3747: a new antiallergic agent for the treatment of immediate hypersensitivity diseases.. Journal of Pharmacology and Experimental Therapeutics. 228(1). 57–64. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact